Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

CVRx raises $84 mil. for hypertension trial: Private placement raises $84 million to fund completion of an ongoing 300-patient, pivotal U.S. trial of CVRx' Rheos implantable device for drug-resistant hypertension, the firm announces July 30. The funds will also go toward building a sales organization in anticipation of eventual PMA approval. The system is designed to stimulate the body's baroreflex to relax blood vessels, and incorporates a small electrical pulse generator implanted under the collar bone, two wire leads that extend to the carotid arteries and an external programmer. Two-year European data released in June show an average systolic blood pressure reduction of 35 mmHg and an average diastolic reduction of 24 mmHg with the device. The Minneapolis firm, which received a CE mark last October, also plans to evaluate Rheos for treatment of heart failure. The privately held company has raised a total of $209 million to date, with New Enterprise Associates and Johnson & Johnson Development Corp. co-leading the most recent funding
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT026410

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel